The SEC helped them reach a path on which to proc
Post# of 75001
"As previously announced, the Company changed audit firms some months ago. In working with the new audit firm, some difficult accounting questions were encountered in connection with the acquisition of the assets of Raw Pharma LLC. The Company and its auditors interacted with the U.S. Securities and Exchange Commission (SEC) on these questions. After discussion with the SEC and with the answer to these questions, the Company and its auditors have a clear path to completion of the audit process. The Company is now in the process of moving forward as quickly as possible to complete and file the Form 10-Q documents for the second and third quarters of 2020."